Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.41 USD
Change Today -0.40 / -2.25%
Volume 69.8K
NVLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 2:39 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arnold Snider

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Mr. Arnold H. Snider, also known as Arnie, was the Founder of Deerfield Management Company L.P. and served as its General Partner. Prior to Deerfield, Mr. Snider served as a Pharmaceutical Analyst at Kidder, Peabody & Co. for 17 years and also worked at Tiger Management. Mr. Snider started two foundations to benefit Lupus Research - Rheuminations, Inc. and the Lupus Clinical Trials Consortium. Mr. Snider served as the Chairman and Director of N30 Pharmaceuticals, LLC. ...

Read Full Background

Corporate Headquarters*

3122 Sterling Circle
Boulder, Colorado 80301

United States

Phone: 720-945-7700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVLS:US $17.41 USD -0.40

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NIVALIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.